TABLE 7.
Univariable Logistic Regression Analysis of Potential Predictors for Successful Imiquimod Treatment (N=47)
| OR (95% CI) | P | |
|---|---|---|
| Age (y) | 1.07 (0.97–1.17) | 0.25 |
| Nulliparity | 3.57 (0.77–16.54) | 0.10 |
| Single sexual partner | 1.00 (0.27–3.76) | 1.00 |
| Previous abnormal cytology | 0.16 (0.02–1.40) | 0.10 |
| CIN II at diagnosis | 0.91 (0.29–2.91) | 0.88 |
| Smoking (recently quit=no) | 0.49 (0.15–1.63) | 0.24 |
| Smoking (recently quit=yes) | 0.33 (0.10–1.09) | 0.07 |
| No. imiquimod applications | 1.00 (1.00–1.00) | 0.81 |
| HPV 16/18 infection at baseline | 1.00 (0.98–1.00) | 0.54 |
CI indicates confidence interval; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; OR, odds ratio.